WASHINGTON (Diya TV) — The U.S. Department of Health and Human Services will recommend fewer routine vaccines for most American children, a policy shift that has alarmed many health experts who fear a return of preventable diseases. Federal officials announced the updated guidance Monday, saying it aims to better tailor immunizations based on individual risk rather than broad age-based schedules.
The move comes as the nation faces a sharp rise in flu cases and growing concern about gaps in childhood vaccination coverage. Public health leaders warn that even small drops in immunization rates can lead to outbreaks of serious illnesses.
Under the revised recommendations, HHS will continue to advise routine vaccinations for several major childhood diseases. These include measles, mumps and rubella, polio, chickenpox, human papillomavirus, and other long-standing immunizations. Officials stressed that these vaccines remain essential for protecting children and communities.
However, the department is narrowing routine recommendations for vaccines against meningococcal disease, hepatitis B, and hepatitis A. Instead of advising these shots for most healthy children, HHS will now recommend them mainly for children considered at higher risk of infection. That group includes children with certain medical conditions or those living in areas with higher exposure risks.
Health officials said the change reflects updated assessments of disease risk. Critics argue that broad vaccination has been key to keeping these illnesses rare in the first place.
The new policy also changes how some common vaccines are recommended. HHS said decisions about flu, COVID-19, and rotavirus vaccines should rely on “shared clinical decision-making.” This approach means parents must consult a health care provider to decide whether their child should receive these shots.
Supporters say shared decision-making allows families to weigh benefits and risks with trusted doctors. Many pediatricians worry the extra step could delay or discourage vaccination, especially for families with limited access to care. The guidance does not change recommendations for respiratory syncytial virus, or RSV. HHS said infants born to mothers who did not receive the RSV vaccine during pregnancy should still get one dose.
Public health experts reacted with concern to the announcement. Many warned that scaling back routine vaccine recommendations could weaken herd immunity and raise the risk of outbreaks. They point to recent increases in measles cases and other preventable diseases as signs of what can happen when vaccination rates slip.
The timing has also raised questions. The changes come amid a significant increase in flu cases across the country. The U.S. Centers for Disease Control and Prevention has reported nine pediatric deaths from flu so far this season. Health officials say flu vaccination remains one of the best ways to prevent severe illness in children.
Doctors also worry about the message sent to parents. Clear and consistent recommendations have long guided childhood immunization schedules. Narrower guidance could create confusion and fuel vaccine hesitancy.
HHS emphasized that insurance coverage will not change. All insurers must still cover these vaccines without cost-sharing, even if they are no longer recommended for all healthy children. That means families should not face direct costs for the shots. Still, experts note that practical barriers may grow. Parents may need extra doctor visits to discuss vaccines that fall under shared decision-making. For working families or those in rural areas, that added step could reduce uptake.
The updated vaccine recommendations highlight an ongoing debate over how best to protect children’s health. Federal officials say the new approach offers flexibility and respects individual choice. Many in the medical community fear it risks undoing decades of progress against infectious diseases.
As schools, parents, and pediatricians adjust to the new guidance, health experts stress the importance of accurate information. Vaccines remain one of the most effective tools in modern medicine. How widely they are used may shape the nation’s public health for years to come.
